NCT03154697Recruiting

Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances

Vanda Pharmaceuticals

Start Date

1/1/2016

Completion Date

12/1/2030

Summary

This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.

Eligibility Criteria

Age Range: 3 years to 65 years

Inclusion Criteria: * Parent or legal guardian of individual with Smith-Magenis Syndrome Exclusion Criteria: * Not legal guardian of individual with SMS

Interventions

OTHER

Data collection of sleep disturbances in individuals with SMS

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Sleep Disturbances in Smith-Magenis Syndrome

Locations

Vanda Pharmaceuticals

Washington D.C., District of Columbia 20037

United States